Age, HGB, platelet count, alanine aminotransferase (ALT) levels, serum albumin levels, bilirubin concentration, LSM, and FIB-4 score were different between the HCC patients and non-HCC patients in the external validation cohort (all p < 0.05; Table 1). The gene discussed is GPT; the disease is hepatocellular carcinoma.